A portrait article about Matthias Egger was published in the March issue of the journal «The Lancet. Infectious diseases.». In the same issue, the publication «Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study» was also published. Continue reading
The 13th INTEREST CONFERENCE will be held in Accra, Ghana from May 14 to 17, 2019.
Known as the “African CROI” the INTEREST Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa.
For more information and to register please go to INTEREST Conference
Matthew Fox, professor of epidemiology and global health and site investigator for the Themba Lethu Clinic in South Africa, joined the editorial board of the Journal of the International AIDS Society as a deputy editor in May 2018.
Fox is co-director of the Health Economics and Epidemiology Research Office (HE2RO) of the Wits Health Consortium, University of the Witwatersrand, Johannesburg, South Africa. In his work at HE2RO, Fox analyzes treatment data to find solutions to bettering HIV treatment, broadening treatment access, and improving outcomes in South Africa, where more than 3 million people are being treated for HIV.
The African Postdoctoral Training Initiative – a partnership of the African Academy of Sciences, the Bill and Melinda Gates Foundation, and the U.S. National Institutes of Health
Application process opens April 11, 2018 – Application deadline May 11, 2018
The African Academy of Sciences (AAS), the U.S. National Institutes of Health (NIH) and the Bill & Melinda Gates Foundation are partnering under the auspices of the Coalition of African Research & Innovation (CARI) to establish a post-doctoral training fellowship program, the African Postdoctoral Training Initiative (APTI). Training will be at a world class institute, the intramural laboratories of NIH.
APTI fellows will train in a global health research area of priority for their home institutions and countries, and AAS, BMGF and NIH, while building bridges and lasting connections between the partner organizations and African scientists and institutions.
amfAR, TREAT Asia and IeDEA are deeply saddened by the loss of Dr. David Cooper, a founding member of the TREAT Asia Network and Director of The Kirby Institute at the University of South Wales in Sydney, Australia. Dr. Cooper died March 18.
Dr. Cooper was internationally recognized as a pioneering researcher and clinician. He was among the first to respond to the HIV epidemic in Australia in the 1980s, and he has been central to the regional fight in the Asia-Pacific against HIV. Continue reading “Mourning the Loss of “A Life on the Front Lines of AIDS Research””
Dr. Sohn leads amfAR’s TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program and chairs the Executive Committee of the NIH-funded IeDEA (International Epidemiology Databases to Evaluate AIDS) global cohort consortium.
HIV drug resistance is increasing rapidly in southern and eastern Africa and Latin America and, as a result, it may soon be necessary to change the recommended first-line antiretroviral drug regimen in many countries to integrase inhibitor-based treatment, according to an analysis published in The Lancet Infectious Diseases on 30 November.